31Oct 2022
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials

Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials

To study the impact of spironolactone on key echocardiographic parameters in HFpEF. A total of 984 patients were included in this analysis: HOMAGE=452 (45.9%), ALDO‐DHF=398 (40.4%), and TOPCAT=134 (13.6%). Spironolactone improved the cardiac structure and function of patients with HFpEF.

  • #cardiology

Like

Save

Share